TickerFacts.

Caris Life Sciences, Inc. (CAI): Shareholders' Equity

Annual figures by period end, from SEC filings.

$577.31M
As of 2025-12-31
$591.73M
As of 2026-06-30
2023-12-31: -$2.14B2024-12-31: -$2.50B2025-12-31: $577.31M$577.31M
2023-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$577.31Mn/m2026-03-03, Balance as of period end
2024-12-31-$2.50Bn/m2026-03-03, Balance as of period end
2023-12-31-$2.14Bn/a2026-03-03, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Caris Life Sciences, Inc. (CAI)2025-12-31$577.31Mn/m
Guardant Health, Inc. (GH)2025-12-31-$99.31Mn/m
Veracyte, Inc. (VCYT)2025-12-31$1.31B+11.4%
CareDx, Inc. (CDNA)2025-12-31$303.10M-19.9%
Castle Biosciences Inc (CSTL)2025-12-31$470.87M+3.3%
RadNet, Inc. (RDNT)2025-12-31$1.36B+19.6%
Fulgent Genetics, Inc. (FLGT)2025-12-31$1.11B-1.9%
BillionToOne, Inc. (BLLN)2025-12-31$480.11Mn/m
Natera, Inc. (NTRA)2025-12-31$1.71B+43.2%

Compare CAI, GH, VCYT, CDNA side by side · Screen every company in Services-Medical Laboratories ↗